Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2020-12-04 14:29:37

Drug firm Zydus Cadila said it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

UNLOCK 5.0

Headlines

Good News

politics

India

World

Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.